A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease

Clinical trial NCT05398029 · COMPLETED

Trial details

NCT number: NCT05398029
Sponsor: Verve Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Heterozygous Familial Hypercholesterolemia Atherosclerotic Cardiovascular Disease Hypercholesterolemia

Start date: 2022-07-05
Primary completion: 2025-02-14
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.